Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-11-08
2005-11-08
Chernyshev, Olga N. (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100, C435S007200, C435S007210, C435S007400, C435S007720, C435S007940, C435S183000, C435S174000, C436S501000, C436S503000, C436S548000, C530S388200
Reexamination Certificate
active
06962793
ABSTRACT:
Methods for diagnosing and monitoring Alzheimer's Disease in a subject comprising measuring hK6 in a sample from the subject. hK6 may be measured using a reagent that detects or binds to hK6, preferably antibodies reactive with hK6.
REFERENCES:
patent: 5733768 (1998-03-01), Dixon et al.
patent: 1092767 (2001-04-01), None
patent: 0576152 (2002-06-01), None
patent: 9-149790 (1997-06-01), None
patent: WO 98/11238 (1998-03-01), None
Ogawa et al., Psychiatry and Clinical Neurosci., 2000, 54, 419-426.
Little et al., J. Biol. Chem., 1997, 272, 40, pp. 25135-25251.
Diamandis, E. et al., “Human Kallikrein 6 (Zyme/Protease M/Neurosin): A New Serum Biomarker of Ovarian Carcinoma”,Clinical Biochemistry, 33(7):579-583 (2000).
Hoffman, BR et al., “Immunofluorometric quantitation and histochemical localization of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavorable prognostic biomarker”,British Journal of Cancer, 87:763-771 (2002).
Little, S. et al., “Zyme, a Novel and Potentially Amyloidogenic Enzyme cDNA Isolated from Alzheimer's Disease Brain”,The Journal of Biological Chemistry, 272(40) 25135-25142 (1997).
Mitsui, S. et al., “Decreased Cerebrospinal Fluid Levels of Neurosin (KLK6), an Aging-Related Protease, as a Possible New Risk Factor for Alzheimer's Disease”,Ann. N.Y. Acad. Sci., 977:216-223 (2002).
Ogawa, K. et al., “Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease”,Psychiatry and Clinical Neurosciences, 54:419-426 (2000).
Petraki, C. et al., “The Spectrum of Human Kallikrein 6 (Zyme/Protease M/Neurosin) Expression in Human Tissues as Assessed by Immunohistochemistry”,The Journal of Histochemistry&Cytochemistry, 49(11):1431-1441 (2001).
Yamanaka, H. et al., “Protease M
eurosin mRNA is expressed in mature oligodendrocytes”,Molecular Brain Research, 71:217-224 (1999).
Yamashiro, K. et al., “Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain”,Biochimica et Biophysica Acta, 1350:11-14 (1997).
Yousef, G. et al., “Molecular Characterization of Zyme/Protease M/Neurosin (PRSS9), a Hormonally Regulated Kallikrein-like Serine Protease”,Genomics, 62(2):251-259 (1999).
Zarghooni, M. et al., “Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients”,Clinical Biochemistry, 35:225-231 (2002).
Chernyshev Olga N.
Merchant & Gould P.C.
Mount Sinai Hospital
LandOfFree
Methods for detecting Alzheimers disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for detecting Alzheimers disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for detecting Alzheimers disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3492997